NEW YORK(GenomeWeb) – Global Enterprises Group today said that it has reached a deal to acquire a majority stake in molecular diagnostics and therapeutics firm Predictive Therapeutics for an undisclosed amount. 

The deal is anticipated to be completed in 10 days, after which changes to Predictive's management and board will be announced, Global said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.